|
Jul 24
|
Lilly and Verve announce expiration of Verve tender offer
|
|
Jul 23
|
Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition
|
|
Jul 14
|
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now.
|
|
Jul 13
|
Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs.
|
|
Jul 10
|
Verve Therapeutics, Inc. (VERV): A Bull Case Theory
|
|
Jun 27
|
BMO downgrades Verve Therapeutics saying Lilly buyout deal caps upside
|
|
Jun 20
|
Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week
|
|
Jun 19
|
What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?
|
|
Jun 19
|
SanDisk initiated, Analog Devices upgraded: Wall Street’s top analyst calls
|
|
Jun 18
|
Verve Therapeutics downgraded to Hold from Buy at Canaccord
|
|
Jun 18
|
Gene-Editing Stocks Gain on LLY-VERV Deal Announcement
|
|
Jun 17
|
Podcast: U.S. Stocks Slip as Israel-Iran Conflict Continues
|
|
Jun 17
|
Stocks to Watch Recap: T-Mobile, Eli Lilly, Verve Therapeutics, First Solar
|
|
Jun 17
|
These Stocks Moved the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, Tesla, T-Mobile, Jabil, and More
|
|
Jun 17
|
Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
|
|
Jun 17
|
Solar stocks, Eli Lilly & Verve, PureCycle: Trending Tickers
|
|
Jun 17
|
Sector Update: Health Care Stocks Retreat Late Afternoon
|
|
Jun 17
|
Eli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bn
|
|
Jun 17
|
Eli Lilly (NYSE:LLY) Eyes US$1.3 Billion Acquisition Of Verve Therapeutics
|
|
Jun 17
|
Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion
|